Tag Archives: treatment

Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases

October 29 2018, Garga K et al There is insufficient evidence to support screening of various tick-borne diseases (TBD) related microbes alongside Borrelia in patients suffering from TBD. To evaluate the involvement of multiple microbial immune responses in patients experiencing TBD we utilized enzyme-linked immunosorbent assay. Four hundred and thirty-two human serum samples organized into seven categories followed Centers for Continues →

Symptoms of Ehrlichiosis [with treatment recommendations]

Nov 26th, 2018 “Patients with ehrlichiosis (regardless of the putative organism) clinically present with fever, chills, severe headache, confusion, malaise, nausea, vomiting, and generalized body aches. Respiratory symptoms such as cough may also be observed, but they are more common in adults than in  children. Symptoms are typically seen one to two weeks following a tick bite, with a median Continues →

Stevia could offer cure for Lyme disease, researchers say

Published July 12th, 2017 Stevia, a common coffee sweetener, could be a possible cure for Lyme disease after tests conducted by a Connecticut professor and her students showed it was most effective in treating the tick-borne illness. Professor Eva Sapi, chairwoman of University of New Haven’s Department of Biology and Environmental Science, and her students have been testing the liquid, whole-leaf Continues →

France: Chronic Lyme is real and treat with long term antibiotics.

Inside Europe: Lyme disease on the rise in France Lyme disease, which you get when bitten by an infected tick, has reached epidemic proportions in France. With 33,000 new officially confirmed cases last year, the government has launched an action plan to fight it. John Laurenson reports from the village of Feucherolles in central France on the spread of a Continues →

LANDMARK PARTNERSHIP PAVES WAY FOR CANADA’S FIRST RESEARCH FACILITY TO IMPROVE LYME DISEASE TESTING AND TREATMENT

New G. Magnotta Lyme Disease Research Lab to be Established at the University of Guelph; $1.4 Million Grant Awarded June 14, 2017 – GUEPLH, Ontario: The G. Magnotta Foundation for Vector-Borne Diseases has announced a $1.4 million grant over three years to the University of Guelph, Department of Molecular and Cellular Biology to undertake Canada’s first evidence-based translational medicine approach Continues →

Johns Hopkins receives $10M to expand research into Lyme disease cause, treatments

Grants from Steven and Alexandra Cohen Foundation support existing research on post-treatment Lyme disease syndrome, new therapies, vulnerable populations   Johns Hopkins University has received a $10 million grant from the Steven and Alexandra Cohen Foundation to explore Lyme disease and develop potential new therapies to address the illness. The grant will be divided among three Johns Hopkins research teams Continues →

Doctor comments on Lyme disease treatment

[CanLyme note: It is very common for mainstream physicians who subscribe to the Infectious Disease Society of America guidelines to design studies in such a fashion that the outcome is pre-determined.  These studies have no value, nor scientific merit.  The divide is created intentionally.] Infectious Disease doctor, Sam Donta, responds to article, To the Editor: I am responding to the Continues →

CBC News, Canada: Lyme disease response requires collaboration in Canada, researcher says

By Laurie Fagan, April 22, 2016 A Queen’s university researcher says Canadian Lyme disease experts need to work more collaboratively to treat the growing number of people who contract the debilitating tick-borne illness. Steven Liss, the vice principal of research at Queen’s University, is proposing a Canadian research network for Lyme disease that would improve the current methods of tracking Continues →

Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime

Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA http://dx.doi.org/10.3389/fmicb.2016.00062  10 February 2016 Lyme disease, caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. While the majority of Lyme disease patients can resolve their symptoms if treated promptly, 10–20% of patients suffer from prolonged symptoms Continues →

Beating Lyme Disease

By Pamela Weintraub July/August 2014 Katina Makris was living her dream when life derailed. A natural-medicine practitioner with a flourishing career, she had a passionate marriage, a young son she doted on, and a home she had lovingly restored in the New Hampshire woods. But slowly she began to slip.   First, in June 2000, there was an inkling of Continues →

Study: Cost of expanded Lyme disease care is low

By Elaine Thompson TELEGRAM & GAZETTE STAFF May 24th, 2013 A report released this week says insurance coverage of long-term antibiotic treatment of chronic Lyme disease would only increase insurance policies by about 13 cents. The information from the state Center for Health Information and Analysis on Thursday is considered to be a major step for House Bill 989, which Continues →

Ontario: Fighting to Recover

By Rob Houle  St. Catherines Standard Sunday, January 19, 2014 Matt Risi wants his life back. For the last 10 years, his health has been in a downward spiral. The bite of an insect that can be the size of the period at the end of this sentence altered his life. Risi has Lyme disease as the result of the bite Continues →